Private Health Insurance and the unaffordability of premiums is one of the most frequently raised issues with CHF by consumers. We welcomed the announcement in October 2016 of reductions of the price of some items on the prostheses list. If these cuts lead to a lower level of premium increase in the next round of premium increases then consumers will benefit. However, to get longer term and more sustainable reductions in premiums the government needs to take a broader, more systemic approach with a robust price disclosure regime across all medical devices. We are also concerned that, other than some commitments in the media, insurers are under no obligation to pass on the savings gained through the recent cuts to consumers.